Newswise — NDCR 2009 by Dr. Daniel A. Hussar, the Remington professor of pharmacy at University of the Sciences' Philadelphia College of Pharmacy, provides a first-of-its-kind reference for pharmacists and healthcare practitioners.
Published by Moore Road Press, NDCR 2009 details the 158 drugs that have been marketed in the U.S. during the 2002-2008 period, and features comparisons to previously marketed drugs, specific advantages and disadvantages of each, and ratings for each new drug based on comparisons with related agents.
To provide an unbiased and comparative analysis of the new drugs marketed each year, Dr. Hussar uses the New Drug Comparison Rating (NDCR) system, a one-to-five point scale he created to succinctly rate a drug's importance based on comparisons with related agents.
Dr. Sarah M. Wieczorkiewicz, clinical assistant professor at the University of Illinois at Chicago College of Pharmacy called NDCR 2009 "an invaluable reference for pharmacists," while Dr. Tim R. Covington, president and CEO of Covington Healthcare Associates said the text presents the "most relevant information about new drugs in a format that is easy to read and comprehend. Any consumer, health professional, insurer/managed care organization or enterprise that objectively evaluates drug therapy could benefit from the content of this book."
Dr. Hussar has written and spoken extensively on the topics of drug interactions, patient compliance, and new drugs. His publications include coverage of all the new therapeutic agents that have been marketed in the U.S. during the last 40 years. His papers on new drugs are published regularly in pharmacy and nursing journals and he speaks frequently on this topic to pharmacists, physicians, and nurses. He currently serves as author/editor of The Pharmacist Activist, a monthly newsletter, and previously served as chief pharmacy editor of Pharmacy Today. The awards and recognitions Dr. Hussar has received include the Distinguished Pharmacy Educator Award of the American Association of Colleges of Pharmacy, the Hugo Schaefer Award of the American Pharmacists Association, and the Rho Chi Pharmacy Honor Society Lecture Award.
For more information or to order this valuable reference, please visit www.newdrugsndcr.com.
At University of the Sciences in Philadelphia, students embark on a challenging learning experience in a proving ground for successful professionals in the healthcare-related fields. A private, coeducational institution dedicated to education, research, and service, and distinguished as the nation's first college of pharmacy, the University has produced leaders in the healthcare marketplace since its founding in 1821, including founders of six of the top pharmaceutical companies in the world. With undergraduate, graduate, and doctoral degree programs in such disciplines as pharmacy, bioinformatics, physical therapy, healthcare business, and health policy, the 3,000 students in the University of the Sciences' five colleges learn to excel in scientific analysis and to apply their skills to improving healthcare in their communities and in the lives of people worldwide. Visit www.usp.edu for more information.
RSS